Literature DB >> 10075377

Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement.

M J Bloch1, D W Trost, T G Pickering, T A Sos, P August.   

Abstract

Pulmonary edema and congestive heart failure (both referred to here as PE) have been reported to be complications of bilateral renal artery stenosis or unilateral stenosis in a solitary functioning kidney (both referred to as BRAS). The goals of this study were to determine whether a history of PE was more common in patients with BRAS than in those with unilateral stenosis and a normal contralateral kidney (URAS), and whether recurrent PE could be prevented by renal artery stent placement. We evaluated 90 consecutive patients with renovascular disease who were treated with percutaneous renal artery stent placement. History and clinical follow-up were obtained through chart review and phone contact with referring physicians. Mean follow-up was 18.4 months after stent placement. Twenty-three of 56 (41%) subjects with BRAS had a history of PE before revascularization, compared with four of 34 (12%) subjects with URAS (P = .05). Twenty-five of the 27 patients with history of PE had adequate clinical follow-up. Seventeen of the 22 (77%) subjects with BRAS and history of PE had no further PE after stent placement in one or both renal arteries. The five BRAS subjects with recurrent PE after stent placement had evidence of stent thrombosis or restenosis. In contrast, only one of three (33%) URAS subjects with a history of PE remained free of PE after stent placement. We conclude that PE is a common complication of BRAS, but not of URAS. In patients with BRAS, recurrent PE can be prevented by successful stent placement in one or both renal arteries.

Entities:  

Mesh:

Year:  1999        PMID: 10075377     DOI: 10.1016/s0895-7061(98)00201-5

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  21 in total

Review 1.  An evidence-based approach to diagnosing renovascular hypertension.

Authors:  M J Bloch
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

2.  Bilateral renovascular disease causing cardiorenal failure.

Authors:  Alison Brammah; Sue Robertson; Graeme Tait; Chris Isles
Journal:  BMJ       Date:  2003-03-01

Review 3.  [Treatment of renal artery stenosis in the year 2021].

Authors:  Tomas Lenz
Journal:  Internist (Berl)       Date:  2021-01-18       Impact factor: 0.743

4.  Flash pulmonary oedema: accurate evaluation of the renal arteries with multislice computed tomography.

Authors:  G Morgan-Hughes; A J Marshall; C Roobottom
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

Review 5.  Atherosclerotic renal artery stenosis: surgery, percutaneous transluminal angioplasty, or medical therapy?

Authors:  P F Plouin; B Guéry; A La Batide Alanore
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

6.  Experience of stenting for atherosclerotic renal artery stenosis in a cardiac catheterization laboratory: technical considerations and complications.

Authors:  Percy P Jokhi; Krishnan Ramanathan; Simon Walsh; Anthony Y Fung; Jacqueline Saw; Rebecca S Fox; Nadia Zalunardo; Christopher E Buller
Journal:  Can J Cardiol       Date:  2009-08       Impact factor: 5.223

Review 7.  Atherosclerotic renovascular hypertension: current trends in diagnosis and management.

Authors:  Kunal Chaudhary; Joshua Botdorf; Adam Whaley-Connell
Journal:  Mo Med       Date:  2011 Jan-Feb

Review 8.  [Current management of renal artery stenosis].

Authors:  T Lenz
Journal:  Internist (Berl)       Date:  2013-12       Impact factor: 0.743

Review 9.  Renal Artery Stenosis: Optimal Therapy and Indications for Revascularization.

Authors:  Sandeep M Patel; Jun Li; Sahil A Parikh
Journal:  Curr Cardiol Rep       Date:  2015-09       Impact factor: 2.931

10.  Pulmonary oedema, think beyond the heart even in the presence of severe left ventricular systolic dysfunction.

Authors:  Shohreh Honarbakhsh; Mohammad Chowdhury; Andrew Deaner; Fahad Farooqi
Journal:  BMJ Case Rep       Date:  2015-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.